Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019 March 26, 2019
Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine® February 25, 2019
Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results November 8, 2018
Titan Strengthens Executive Leadership Team With Appointment Of Chief Commercial Officer October 2, 2018
Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse September 10, 2018
Titan And The Nevada Center For Behavioral Health Collaborate To Evaluate Probuphine® Treament Of OUD Patients Within The State Of Nevada Criminal Justice System September 4, 2018
